FOXO TECHNOLOGIES INC. Statutory Accounting Practices, Statutory Capital and Surplus Required
FOXO TECHNOLOGIES INC. (FOXO) had Statutory Accounting Practices, Statutory Capital and Surplus Required of $4.75 million as of 2023-12-31, per its 10-K filed 2024-06-06.
Financial Statements › Notes › Financial Services
us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired · last filed 2025-04-15
- 2023-12-31: Statutory Accounting Practices, Statutory Capital and Surplus Required $4.75M.
- 2023-03-31: Statutory Accounting Practices, Statutory Capital and Surplus Required $5.00M.
- 2023-02-03: Statutory Accounting Practices, Statutory Capital and Surplus Required $5.00M; Statutory Accounting Practices, Statutory Capital and Surplus Required as first filed $5.00M.
- 2022-12-31: Statutory Accounting Practices, Statutory Capital and Surplus Required $5.00M.
| Period end | Statutory Accounting Practices, Statutory Capital and Surplus Required | Statutory Accounting Practices, Statutory Capital and Surplus Required as first filed |
|---|---|---|
| 2023-12-31 | $4.75M 10-K · filed 2024-06-06 | |
| 2023-03-31 | $5.00M 10-Q · filed 2023-05-11 | |
| 2023-02-03 | $5.00M 10-K · filed 2025-04-15 | $5.00M 10-Q · filed 2023-08-10 |
| 2022-12-31 | $5.00M 10-K · filed 2024-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |